Search Results - Xiaocheng Li-Sucholeiki

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    Performance characteristics of a polymerase chain reaction-based assay for the detection of EGFR mutations in plasma cell-free DNA from patients with non-small cell lung cancer using cell-free DNA collection tubes

    Performance characteristics of a polymerase chain reaction-based assay for the detection of EGFR mutations in plasma cell-free DNA from patients with non-small cell lung cancer usi... by May, Theresa, Clement, Michelle S, Halait, Harkanwal, Kohlmann, Alexander, Kohlmann, Milena, Lai, Jason, Lee, Nitta, Li-Sucholeiki, Xiaocheng, Meldgaard, Peter, Joshi, Snehal, Scudder, Sidney, Shrestha, Neelima, Sorensen, Boe, Kiral, Marilyn, O'Donnell, Patrick

    Published in PloS one
    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  2. 2
    Tissue and Plasma EGFR Mutation Analysis in the FLAURA Trial: Osimertinib versus Comparator EGFR Tyrosine Kinase Inhibitor as First-Line Treatment in Patients with EGFR-Mutated Advanced Non-Small Cell Lung Cancer

    Tissue and Plasma EGFR Mutation Analysis in the FLAURA Trial: Osimertinib versus Comparator EGFR Tyrosine Kinase Inhibitor as First-Line Treatment in Patients with EGFR-Mutated Adv... by Gray, Jhanelle E, Okamoto, Isamu, Sriuranpong, Virote, Vansteenkiste, Johan, Imamura, Fumio, Lee, Jong Seok, Pang, Yong-Kek, Cobo, Manuel, Kasahara, Kazuo, Cheng, Ying, Nogami, Naoyuki, Cho, Eun Kyung, Su, Wu Chou, Zhang, Guili, Huang, Xiangning, Li-Sucholeiki, Xiaocheng, Lentrichia, Brian, Dearden, Simon, Jenkins, Suzanne, Saggese, Matilde, Rukazenkov, Yuri, Ramalingam, Suresh S

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Biomarker-Directed Phase II Platform Study in Patients With EGFR Sensitizing Mutation-Positive Advanced/Metastatic Non-Small Cell Lung Cancer Whose Disease Has Progressed on First-Line Osimertinib Therapy (ORCHARD)

    Biomarker-Directed Phase II Platform Study in Patients With EGFR Sensitizing Mutation-Positive Advanced/Metastatic Non-Small Cell Lung Cancer Whose Disease Has Progressed on First-... by Yu, Helena A., Goldberg, Sarah B., Le, Xiuning, Piotrowska, Zofia, Goldman, Jonathan W., De Langen, Adrianus J., Okamoto, Isamu, Cho, Byoung Chul, Smith, Paul, Mensi, Ilhem, Ambrose, Helen, Kraljevic, Silvija, Maidment, Julie, Chmielecki, Juliann, Li-Sucholeiki, Xiaocheng, Doughton, Gail, Patel, Gargi, Jewsbury, Phil, Szekeres, Phil, Riess, Jonathan W.

    Published in Clinical lung cancer
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Performance characteristics of a polymerase chain reaction-based assay for the detection of EGFR mutations in plasma cell-free DNA from patients with non-small cell lung cancer using cell-free DNA collection tubes

    Performance characteristics of a polymerase chain reaction-based assay for the detection of EGFR mutations in plasma cell-free DNA from patients with non-small cell lung cancer usi... by Theresa May, Michelle S. Clement, Harkanwal Halait, Alexander Kohlmann, Milena Kohlmann, Jason Lai, Nitta Lee, Xiaocheng Li-Sucholeiki, Peter Meldgaard, Snehal Joshi, Sidney Scudder, Neelima Shrestha, Boe Sorensen, Marilyn Kiral, Patrick O’Donnell

    Published in PloS one
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: